Atlas Trials

Safety Evaluation of China Patients: Long-term Treatment Outcome of Conbercept Ophthalmic Injection in Real Word(STONE)

Clinical trial NCT03054818 · UNKNOWN

Trial details

NCT number
NCT03054818
Sponsor
Chengdu Kanghong Biotech Co., Ltd.
Status
UNKNOWN
Study type
OBSERVATIONAL
Wet Age-related Macular Degeneration (wAMD)
Start date
2016-10-01
Primary completion
2018-06-01
Enrollment
4000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.